In early August, the price of PA6 fell in a narrow range

1、 Price trend:

 

According to the business club’s big list data, the domestic PA6 market continued to be weak in the first ten days of August, and most brand spot prices were reduced. As of August 10, the mainstream offer price of 2.75-2.85 from traders was about 10833.33 yuan / ton, a decrease of 0.91% compared with the average price at the beginning of the month.

 

Sodium Molybdate

2、 Analysis of influencing factors:

 

The price of caprolactam in the upstream of PA6 fell sharply in the first ten days of August. As of August 7, the average ex factory price was 9416 yuan / ton, down 1.22%. Raw material pure benzene by multiple positive boost, recent prices continue to rise. But pure benzene port inventory goes up, restricting the market to pick up. Caprolactam analysts believe that although the price of raw material pure benzene rose, but downstream demand performance is still weak, caprolactam market is not optimistic. It is expected that the price of caprolactam will be weak and stable in the short term.

 

PA6 continued the negative trend of July low in early August. The upstream caprolactam fell and the cost support weakened. PA6 consumption weakened, overall lack of good news to boost, price shocks fell. In terms of business operation, they prefer stable price delivery. Downstream factories follow up generally and have a heavy wait-and-see attitude. Their operation mainly focuses on low-cost replenishment and instant use, and their strategy tends to small-scale procurement.

 

3、 Future forecast:

 

Business agency analysts believe that: in early August, domestic PA6 market narrowly fell, and spot prices of various brands were adjusted. The upstream caprolactam had a significant downward trend, and the support for the cost side of PA6 was weakened. The demand of downstream factories is weak, just need to buy mainly, PA6 trading volume and consumption is weak, business mentality is not strong, there is profit reduction operation. It is expected that PA6 market will continue the weak trend in the near future.

povidone Iodine